Ventyx Biosciences
VTYX
NASDAQ
IPO2021
about VTYX
Ventyx Biosciences is a biopharmaceutical company focused on developing innovative treatments for various health conditions.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $15.32 | $15.34 | $13.43 | $717.15M | 28.07M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.32 | n/a | n/a | 0% | 0% | 0% |